Shares of medical device company DexCom (NASDAQ:DXCM) fell 2.6% in the morning session after analysts at Piper Sandler and ...

Supermodels, singers, and diabetics are all wearing it. Jake Leach, Dexcom CEO, says these sensors are the future.

(Nasdaq: DXCM) today reported preliminary, unaudited results for the fourth quarter ended December 31, 2025 with total ...

Shares rose 6.7% to $71.95, putting the stock on pace for its highest close since last September, according to Dow Jones ...

The S&P 500 Index ($SPX) (SPY) on Monday closed up +0.16%, the Dow Jones Industrials Index ($DOWI) (DIA) closed up +0.17%, ...

DexCom, Inc. , the global leader in glucose biosensing, is ushering in the next era of transformative, customer-driven innovation under the leadership of President and CEO Jake Leach, who assumed his ...

MakeMyTrip Limited plans to report its fiscal 2026 third quarter financial and operating results before markets open on ...

FDA plans limited regulation of wearable medical devices, boosting Apple, Fitbit, Oura stocks as 50% of Americans use fitness ...

Jan 6 (Reuters) - The U.S. Food and Drug Administration said on Tuesday that it will limit regulation of wearable devices ...

Bernstein analyst Lee Hambright maintained a Buy rating on Dexcom today and set a price target of $86.00. According to TipRanks, Hambright is a 4-star analyst with an average return of 8.1% and a ...

Contract Inflows and Solid Backlog Aid Leidos Holdings (LDOS) According to the Zacks analyst, Leidos Holdings is benefiting ...

WASHINGTON (AP) — U.S. filings for jobless benefits rose in the last week of 2025 but remain historically low, despite signs that the labor market is weakening.